Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Single-Center Retrospective Analysis

B. R. Shank, B. Primeaux, E. K. Yeung, S. B. Horowitz, I. Y. Lee, L. Roccograndi, L. Feng, G. P. Kaufman, H. C. Lee, E. E. Manasanch, K. K. Patel, R. Z. Orlowski, D. M. Weber, M. R. Becnel, S. K. Thomas

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Single-Center Retrospective Analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences